Creative Planning Increases Stock Holdings in DENTSPLY SIRONA Inc. $XRAY

Creative Planning grew its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 311.9% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 113,875 shares of the medical instruments supplier’s stock after purchasing an additional 86,227 shares during the period. Creative Planning owned approximately 0.06% of DENTSPLY SIRONA worth $1,808,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of XRAY. Brooklyn Investment Group acquired a new position in DENTSPLY SIRONA in the 1st quarter valued at $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of DENTSPLY SIRONA in the first quarter valued at about $26,000. Trust Co. of Toledo NA OH acquired a new position in shares of DENTSPLY SIRONA during the second quarter worth about $27,000. Parkside Financial Bank & Trust raised its holdings in DENTSPLY SIRONA by 620.6% during the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock worth $27,000 after purchasing an additional 1,477 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd lifted its position in DENTSPLY SIRONA by 8,003.6% in the first quarter. Caitong International Asset Management Co. Ltd now owns 2,269 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 2,241 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Stock Up 1.8%

DENTSPLY SIRONA stock opened at $11.29 on Thursday. DENTSPLY SIRONA Inc. has a fifty-two week low of $9.85 and a fifty-two week high of $20.59. The firm has a market capitalization of $2.25 billion, a price-to-earnings ratio of -2.38, a price-to-earnings-growth ratio of 0.81 and a beta of 1.00. The stock’s fifty day moving average is $12.13 and its two-hundred day moving average is $14.17. The company has a debt-to-equity ratio of 1.13, a quick ratio of 1.11 and a current ratio of 1.69.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $0.37 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.08). The business had revenue of $904.00 million during the quarter, compared to analysts’ expectations of $900.33 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.DENTSPLY SIRONA’s quarterly revenue was down 4.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.50 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. Analysts predict that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have recently issued reports on XRAY. Evercore ISI cut their target price on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a research note on Wednesday, October 8th. Wall Street Zen lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, October 18th. JPMorgan Chase & Co. reduced their target price on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Friday, November 7th. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a research report on Friday, September 26th. Finally, Zacks Research cut shares of DENTSPLY SIRONA from a “hold” rating to a “strong sell” rating in a research note on Monday, November 10th. Two research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $16.08.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.